Versor Investments’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-30,648
| Closed | -$3.5M | – | 740 |
|
|
2025
Q1 | $3.5M | Buy |
30,648
+18,448
| +151% | +$2.11M | 0.57% | 16 |
|
|
2024
Q4 | $615K | Sell |
12,200
-12,600
| -51% | -$635K | 0.11% | 305 |
|
|
2024
Q3 | $1.15M | Buy |
+24,800
| New | +$1.15M | 0.18% | 153 |
|
|
2024
Q2 | – | Sell |
-22,710
| Closed | -$572K | – | 759 |
|
|
2024
Q1 | $572K | Sell |
22,710
-14,668
| -39% | -$369K | 0.12% | 293 |
|
|
2023
Q4 | $1.21M | Buy |
37,378
+14,565
| +64% | +$473K | 0.25% | 88 |
|
|
2023
Q3 | $622K | Buy |
22,813
+11,613
| +104% | +$316K | 0.13% | 230 |
|
|
2023
Q2 | $249K | Buy |
+11,200
| New | +$249K | 0.04% | 485 |
|
|
2023
Q1 | – | Sell |
-29,148
| Closed | -$592K | – | 731 |
|
|
2022
Q4 | $592K | Buy |
29,148
+16,855
| +137% | +$342K | 0.05% | 294 |
|
|
2022
Q3 | $315K | Sell |
12,293
-48,596
| -80% | -$1.25M | 0.02% | 583 |
|
|
2022
Q2 | $1.45M | Buy |
60,889
+42,989
| +240% | +$1.02M | 0.06% | 150 |
|
|
2022
Q1 | $403K | Sell |
17,900
-5,265
| -23% | -$119K | 0.02% | 389 |
|
|
2021
Q4 | $459K | Buy |
+23,165
| New | +$459K | 0.01% | 285 |
|
|
2021
Q2 | – | Sell |
-14,700
| Closed | -$350K | – | 355 |
|
|
2021
Q1 | $350K | Buy |
+14,700
| New | +$350K | 0.02% | 175 |
|
|
2017
Q4 | – | Sell |
-30,400
| Closed | -$587K | – | 248 |
|
|
2017
Q3 | $587K | Buy |
30,400
+16,600
| +120% | +$321K | 0.19% | 56 |
|
|
2017
Q2 | $163K | Buy |
+13,800
| New | +$163K | 0.04% | 178 |
|